Skip to main content
GINWA ENTERPRISE (GROUP) INC. logo

GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings

Ticker · 600080 ISIN · CNE000000QQ8 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,715 across all filing types
Latest filing 2021-02-04 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600080

About GINWA ENTERPRISE (GROUP) INC.

http://www.ginwa.com.cn/

Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.

Recent filings

Filing Released Lang Actions
金花企业（集团）股份有限公司关于再次延期回复上海证券交易所对ST金花募集资金存储银行未执行划款指令问询函的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about the company's fundraising bank not executing payment instructions. It references multiple previous announcements about the delay and states the company will reply by a new extended deadline. The document is short (1006 characters) and primarily serves as a regulatory update on the status of the inquiry response, without containing financial statements or detailed financial data. It is not a full report, audit, or earnings release, but rather a regulatory compliance announcement. Therefore, it fits best under Regulatory Filings (RNS).
2021-02-04 Chinese
金花企业（集团）股份有限公司关于再次延期回复上海证券交易所对公司股东权益变动事项问询函的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about changes in shareholder equity. It references multiple previous announcements about the delay and states the company will respond by a new extended deadline. The document does not contain financial statements, audit results, or detailed financial data. It is a regulatory update about compliance and disclosure obligations related to shareholder equity inquiries. The document length is short (1109 characters) and it is an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-02-02 Chinese
金花企业（集团）股份有限公司关于再次延期回复上海证券交易所对ST金花募集资金存储银行未执行划款指令问询函的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about the company's fundraising funds storage bank not executing payment instructions. It references previous announcements about the delay and states a new expected reply date. The document is short (994 characters) and primarily serves as a regulatory update on the status of the inquiry response, without containing financial statements or detailed financial data. It is not a full report but an announcement related to regulatory compliance and disclosure obligations. Therefore, it fits best under Regulatory Filings (RNS).
2021-01-28 Chinese
金花企业（集团）股份有限公司关于再次延期回复上海证券交易所对公司股东权益变动事项问询函的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about changes in shareholder equity. It details multiple previous announcements about postponing the reply and states the company will further delay the response. The document is short (1091 characters) and does not contain financial statements or detailed financial data. It is an announcement about regulatory communication and disclosure obligations rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-01-26 Chinese
金花企业（集团）股份有限公司关于收到上海证券交易所督促公司尽快回复前期问询函相关事项监管工作函的公告
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company responding to a regulatory inquiry from the Shanghai Stock Exchange regarding shareholder equity changes and fund custody issues. It contains no financial statements or detailed financial data, but rather a disclosure about the company's obligation to respond to the inquiry and update investors. The document is short (1085 characters) and serves as a formal announcement of regulatory communication and compliance status. It does not contain an actual report or financial results, nor is it a certification letter or voting result. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures.
2021-01-22 Chinese
金花企业（集团）股份有限公司2020年年度业绩预增公告
Regulatory Filings Classification · 95% confidence The document is a 2020 annual performance forecast announcement by the company, providing preliminary estimated net profit increases for the fiscal year 2020. It explicitly states that the data is preliminary, unaudited, and that the final audited financial data will be disclosed in the formal 2020 annual report. The document is short (993 characters) and serves as a performance forecast rather than a full financial report. It does not contain actual financial statements or detailed financial analysis, so it is not an Annual Report (10-K) or Interim Report (IR). It is also not an Earnings Release (ER) since it is a forecast, not an initial quarterly or periodical financial result announcement. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of a performance forecast that does not fit other specific categories.
2021-01-22 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.